BrainMARC
Wearable, EEG-based Tools for Mental Evaluation
Company Overview
Snapshot
Founded in March 2013 by Goded Shahaf, BrainMARC operates with 1–10 employees. The company has secured funding across one disclosed round from one investor. BrainMARC holds a patent for its proprietary algorithm, which is in the national phase globally.
Business overview
BrainMARC develops a digital platform for cognitive remediation, leveraging its Brain Engagement Index (BEI) technology. This proprietary algorithm extracts the BEI to measure patient attention levels during cognitive exercises. The platform offers an easy-to-use solution for objective attention measurement, contrasting with multi-electrode EEG systems. BrainMARC's solution aims to optimize therapy sessions and improve overall effectiveness for patients with cognitive impairments. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics, serving healthcare providers globally.
Strategic signal
BrainMARC's technology, which focuses on objective measurement of attention during cognitive exercises, has been highlighted in discussions about Israeli technology finding a home in the Canadian health system. This indicates potential for international market penetration and validation of its digital therapeutics platform in established healthcare systems, signaling a pathway for broader adoption and strategic partnerships.
Log in to access full profile ›Company Intelligence Q&A
- What is BrainMARC's core technology?
- BrainMARC's core technology is its Brain Engagement Index (BEI) algorithm, which extracts a patient's attention level during cognitive exercises using a digital platform for cognitive remediation.
- When was BrainMARC founded?
- BrainMARC was founded in March 2013.
- What is the status of BrainMARC's operations?
- BrainMARC is currently non-active, having ceased operations in December 2019.
- Has BrainMARC's technology been clinically validated?
- Yes, BrainMARC's platform has been validated by hundreds of patient cases in clinical settings across the United States, Canada, Europe, and Israel.
- What is the status of BrainMARC's patent application?
- BrainMARC's proprietary algorithm patent application is in the national phase globally.